{
  "meeting_annotations": [
    {
      "speaker": "mark sellmyer",
      "timestamp": "00:05-00:07",
      "transcript": "I guess how much clinicians get paid, it's uh, you know.",
      "speaking duration": 2,
      "nods_others": 0,
      "smile_self": 100.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Benjamin Bartelle",
      "timestamp": "00:07-00:13",
      "transcript": "Okay. Sorry guys, it's a big part of it.",
      "speaking duration": 6,
      "nods_others": 0,
      "smile_self": 100.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "mark sellmyer",
      "timestamp": "00:14-00:33",
      "transcript": "As the as the clinician on the call, I can't defend anything here, but I guess the um, the the thing that strikes me is is the sheer just amount of research that needs to go in to validate safety and the amount of time that that takes and effort.",
      "speaking duration": 19,
      "nods_others": 1,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "mark sellmyer",
      "timestamp": "00:33-00:57",
      "transcript": "And then doing, you know, to get something to as an imaging probe, it's actually frankly somewhat markedly easier to get into the clinic than it is for a therapeutic where imaging probes generally are benign, right? They're not going to kill you, a radio tracer is low, MR contrast agents may be harder.",
      "speaking duration": 24,
      "nods_others": 2,
      "smile_self": 50.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "Open Palms",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Benjamin Bartelle",
      "timestamp": "00:57-01:01",
      "transcript": "Somehow we've convinced people of this. Yeah, it's amazing. But yeah.",
      "speaking duration": 4,
      "nods_others": 1,
      "smile_self": 100.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Dr. Anna Moore",
      "timestamp": "01:01-01:06",
      "transcript": "Well, yeah, because, you know, radio tracer, you inject them in such a small, small quantity that, you know, it's.",
      "speaking duration": 5,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "Pointing",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Benjamin Bartelle",
      "timestamp": "01:07-01:09",
      "transcript": "Oh yeah, I'm talking about Gadolinium. That's just.",
      "speaking duration": 2,
      "nods_others": 0,
      "smile_self": 100.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "Yes",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Dr. Anna Moore",
      "timestamp": "01:09-01:11",
      "transcript": "Yeah, Gadolinium.",
      "speaking duration": 2,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Benjamin Bartelle",
      "timestamp": "01:11-01:15",
      "transcript": "It's some reason it's okay to put in millimolar amounts of Gadolinium into a person.",
      "speaking duration": 4,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Dr. Anna Moore",
      "timestamp": "01:15-01:17",
      "transcript": "Well, there's a warning on the label.",
      "speaking duration": 2,
      "nods_others": 0,
      "smile_self": 100.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "Open Palms",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Benjamin Bartelle",
      "timestamp": "01:17-01:18",
      "transcript": "The debate the debate rages, yeah.",
      "speaking duration": 1,
      "nods_others": 0,
      "smile_self": 100.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "Open Palms",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "mark sellmyer",
      "timestamp": "01:22-01:33",
      "transcript": "But but I think, you know, the therapeutic index for a therapy is a huge deal, right? If you you don't want to be causing toxicity and in the realm of do no harm, right? It it just takes us.",
      "speaking duration": 11,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "mark sellmyer",
      "timestamp": "01:33-01:45",
      "transcript": "So so Sian, I I I don't know how to answer the question other than to say like as imagers, we actually are in a better position of um, getting things translated.",
      "speaking duration": 12,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "mark sellmyer",
      "timestamp": "01:45-02:12",
      "transcript": "So like, you know, this was there's image guided therapies being here. People have developed fluorescent probes to thing like folate receptor or looking at um ICG for various lung cancers. So people have taken, you know, molecular imaging approaches and put those into patients without a huge, you know, long, long time to get those um, we're talking years rather than 10 years maybe to do this.",
      "speaking duration": 27,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Dr. Anna Moore",
      "timestamp": "02:12-02:31",
      "transcript": "Well, but you know, answering your question uh Sian is um, you know, just just look at the catalog from uh Charles River, you know, how much you pay for a transgenic animal. You know, it's like 250 bucks for one mouse.",
      "speaking duration": 19,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "Open Palms",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Benjamin Bartelle",
      "timestamp": "02:31-02:33",
      "transcript": "That's a deal.",
      "speaking duration": 2,
      "nods_others": 0,
      "smile_self": 100.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Benjamin Bartelle",
      "timestamp": "02:33-02:37",
      "transcript": "We transgenic GQ animals, 400 bucks anyway.",
      "speaking duration": 4,
      "nods_others": 0,
      "smile_self": 100.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Dr. Anna Moore",
      "timestamp": "02:37-03:12",
      "transcript": "I know. I'm with you, I'm with you. I know. And yeah, those are even higher. And then you need n equals more than three, right? To do anything, you know, anything meaningful. And then um, all the antibodies and everything, and then once you're done with the with the with the pre-clinical studies in your lab.",
      "speaking duration": 35,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "Open Palms",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Dr. Anna Moore",
      "timestamp": "03:12-03:42",
      "transcript": "You go to CROs, uh, which are contract research organizations to do tox, to do PKPD, that's all required by FDA. And I hate to show you the bills from those companies because I went through that with my uh, with the compound that we're developed. You just, you know, basically wondering, you know, how can you possibly pay for all that? So, and then, uh, the companies that, you know, they invest money in this and then they want to recover those money and then we're wondering why the drugs are so expensive because if so much money you want to recover it somehow, right?",
      "speaking duration": 30,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "Open Palms",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Benjamin Bartelle",
      "timestamp": "03:42-03:43",
      "transcript": "There's a ray of light.",
      "speaking duration": 1,
      "nods_others": 0,
      "smile_self": 100.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Benjamin Bartelle",
      "timestamp": "03:43-04:11",
      "transcript": "And that this builds on something Dylan brought up earlier is um, you were saying you're using clinically approved drugs in your your studies and that sort of gives you a shortcut, right? With the 90% of investment in new medicines is in biologic drugs. Most of these are antibody based drugs, right? And they're going after specific targets.",
      "speaking duration": 28,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Benjamin Bartelle",
      "timestamp": "04:11-04:51",
      "transcript": "Like I made an antibody against this target, antibody against that target, I've proved that it's focal enough where it doesn't cause the worst side effects. Because of the modularity of nanotechnology and biological systems, the what everyone is doing right now, at least in the synthetic biology space, is they're starting with that. like we know this biologic drug hits this target safely. And so now we're going to build a car T cell therapy around that biologic drug.",
      "speaking duration": 40,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "Open Palms",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Benjamin Bartelle",
      "timestamp": "04:51-05:09",
      "transcript": "We know that this drug goes hits T cells specifically. Great, we're building a theragnostic that's going to find the T cells and report back to us that it's done a job in it. So we have there is a way of bypassing some of that initial safety testing if you do go with these um biologics or just antibodies that are already approved. So there there's some hope there and I think the as we get better and better at this, we may start building out something like a grass list, you know, it's like generally recognized as safe list.",
      "speaking duration": 18,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "Open Palms",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "mark sellmyer",
      "timestamp": "05:10-05:11",
      "transcript": "Good points.",
      "speaking duration": 1,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Dr. Anna Moore",
      "timestamp": "05:12-05:51",
      "transcript": "But but I'm still wondering if, you know, wouldn't it be great if every single drug that you uh inject has somewhat some kind of an image image guided guidance image guiding properties. So you can monitor this drug.",
      "speaking duration": 39,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "Open Palms",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Dr. Anna Moore",
      "timestamp": "05:51-06:02",
      "transcript": "Uh, without sacrificing, you know, many, many animals. And avoiding those costly studies that you have to pay for because you can actually do it yourself.",
      "speaking duration": 11,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Dr. Anna Moore",
      "timestamp": "06:02-06:03",
      "transcript": "Because you can get quantitative data.",
      "speaking duration": 1,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Sixian You",
      "timestamp": "06:03-06:13",
      "transcript": "So what I'm hearing is that uh, so for therapies, the major barrier is actually in biology is in in the therapies.",
      "speaking duration": 10,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Sixian You",
      "timestamp": "06:13-06:30",
      "transcript": "It's not image guiding technologies. But if we want to develop image guiding technologies, it will be helpful to develop something that can monitor these early changes induced by the drugs.",
      "speaking duration": 17,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "Pointing",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Sixian You",
      "timestamp": "06:30-06:33",
      "transcript": "So either is the delivery of the.",
      "speaking duration": 3,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Dr. Anna Moore",
      "timestamp": "06:33-06:34",
      "transcript": "With companion diagnostics.",
      "speaking duration": 1,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "Yes",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Sixian You",
      "timestamp": "06:34-06:36",
      "transcript": "Companion diagnostics.",
      "speaking duration": 2,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Molly Bright",
      "timestamp": "06:37-06:42",
      "transcript": "Can I weigh in on a completely different take on on I guess yeah.",
      "speaking duration": 5,
      "nods_others": 0,
      "smile_self": 100.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Molly Bright",
      "timestamp": "06:44-07:10",
      "transcript": "So I think about it from the other end and I guess I'm surrounded by very long-term treatments and also ambiguous treatments. So there are so many therapeutics and drugs that we use in humans that may or may not work for someone, we don't know how to dose it and we don't have an imaging marker of what it's doing particularly in the brain.",
      "speaking duration": 26,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Molly Bright",
      "timestamp": "07:10-07:40",
      "transcript": "Um, so that's that's my domain would be the brain, that's unfortunately what I can focus on. But there are so many drugs that I think sit into this category and if you think of all of the mood disorders and anything to do with mental health, anything to do with long-term degeneration of neural function uh and and dementia.",
      "speaking duration": 30,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Molly Bright",
      "timestamp": "07:40-07:43",
      "transcript": "We need a time scale of looking at.",
      "speaking duration": 3,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Molly Bright",
      "timestamp": "07:43-08:02",
      "transcript": "What a drug does and what happens in the absence of that drug in the face of huge human variability to evaluate if we're remotely close to getting after what we're after.",
      "speaking duration": 19,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "Open Palms",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Molly Bright",
      "timestamp": "08:02-08:04",
      "transcript": "And that is a huge cost.",
      "speaking duration": 2,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Molly Bright",
      "timestamp": "08:04-08:10",
      "transcript": "Sorry, downer.",
      "speaking duration": 6,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "mark sellmyer",
      "timestamp": "08:10-08:11",
      "transcript": "Well, I don't know.",
      "speaking duration": 1,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "mark sellmyer",
      "timestamp": "08:11-08:18",
      "transcript": "Is hyperpolarized a way forwards to look at function in the brain using hyperpolarized substrates with MRI?",
      "speaking duration": 7,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Molly Bright",
      "timestamp": "08:18-08:20",
      "transcript": "Is that really going to get at the.",
      "speaking duration": 2,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Molly Bright",
      "timestamp": "08:20-08:47",
      "transcript": "The limitation of this scale of treatment efficacy? Yeah.",
      "speaking duration": 27,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "mark sellmyer",
      "timestamp": "08:51-08:57",
      "transcript": "Right. So so efficacy as measured by some um, for psychiatric disease.",
      "speaking duration": 6,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "mark sellmyer",
      "timestamp": "08:57-09:02",
      "transcript": "Really hard to measure, well, harder to measure than let's say a tumor size, you know.",
      "speaking duration": 5,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 100.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    },
    {
      "speaker": "Benjamin Bartelle",
      "timestamp": "09:58-10:01",
      "transcript": "almost worse that we have the wrong.",
      "speaking duration": 3,
      "nods_others": 0,
      "smile_self": 0.0,
      "smile_other": 0.0,
      "distracted_others": 0,
      "hand_gesture": "None",
      "interuption": "No",
      "overlap": "No",
      "screenshare": "No",
      "screenshare_content": "None"
    }
  ]
}